JD Health International Inc. (HKG:6618)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
34.74
+0.10 (0.29%)
Sep 11, 2026, 4:08 PM HKT

JD Health International Stock Forecast

Stock Price Forecast

According to 18 analysts polled by S&P Global, JD Health International stock has a consensus rating of "Strong Buy" and an average price target of $68.47. The average 1-year stock price forecast is 97.09% higher than the current stock price, while the lowest is $49.84 (+43.47%) and the highest is $95.82 (+175.82%).

Price Target: $68.47 (+97.09%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$49.84$68.47$67.04$95.82
Change+43.47%+97.09%+92.98%+175.82%

Analyst Ratings

The average analyst rating for JD Health International stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy151414141414
Buy333333
Hold111111
Sell000000
Strong Sell000000
Total191818181818

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Citic Securities
No rating
Citic Securities
Buy
Maintains
$74.00
BuyMaintains$74.00+113.01%Aug 27, 2026
Unknown Analyst
Goldman Sachs
No rating
Goldman Sachs
Buy
Maintains
$65.00$59.00
BuyMaintains$65.00$59.00+69.83%Aug 18, 2026
Jefferies
Jefferies
Buy
Maintains
$80.00
BuyMaintains$80.00+130.28%Aug 17, 2026
Unknown Analyst
Huatai Securities
No rating
Huatai Securities
Buy
Maintains
$70.20
BuyMaintains$70.20+102.07%Aug 17, 2026
Unknown Analyst
CSC Financial
No rating
CSC Financial
Buy
Maintains
$58.27
BuyMaintains$58.27+67.73%Aug 16, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
85.92B
from 73.44B
Increased by 16.99%
Revenue Next Year
99.13B
from 85.92B
Increased by 15.37%
EPS This Year
2.13
from 2.04
Increased by 4.09%
EPS Next Year
2.51
from 2.13
Increased by 18.14%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
30.68B46.74B53.53B58.16B73.44B85.92B
Revenue Growth
58.30%52.32%14.54%8.65%26.28%16.99%
Gross Profit
7.20B9.89B11.87B13.31B18.20B21.70B
Gross Margin
23.46%21.16%22.17%22.88%24.78%25.25%
Operating Income
-1.40B-145.12M630.85M1.16B3.80B5.30B
Net Income
-1.07B380.11M2.14B4.16B5.38B5.96B
EPS
----2.042.13
EPS Growth
----34.79%4.09%
Forward PE
112.3267.4026.4117.6024.3713.96
Free Cash Flow
3.22B3.16B2.75B2.35B7.24B7.19B
No. Analysts
-----16
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High87.0B
Avg85.9B
Low85.2B

Revenue Growth

Revenue Growth202620272028
High
18.4%
Avg
17.0%
Low
16.0%

EPS Forecast

EPS202620272028
High2.20
Avg2.13
Low1.89

EPS Growth

EPS Growth202620272028
High
7.6%
Avg
4.1%
Low
-7.5%